Frontline Ltd.'s preliminary first quarter 2017 results will be released on Tuesday May 30, 2017 and a webcast and conference call will be held at 3:00 p.m. CET (9:00 a.m U.S. Eastern Time). The results presentation will be available for download from the Investor Relations section at www.frontline.bm ahead of the conference call.
In order to attend the conference call you may do one of the following:
a. Webcast
Go to the Investor Relations section at www.frontline.bm and follow the "Webcast" link.
b. Conference Call
Participant dial-in telephone numbers:
International Dial-In/UK Local +44(0)20 3427 1905
Norway +472350 0486
Norway Toll Free 800 56054
UK Toll Free 0800 279 4992
USA Toll Free 1877 280 1254
USA Local +1646 254 3362
Conference ID 6041861
Participants will be asked for their full name & Conference ID.
A Q&A session will be held after the teleconference/webcast. Information on how to submit questions will be given at the beginning of the session.
The presentation material which will be used in the teleconference/webcast can be downloaded from www.frontline.bm.
Replay details (available for 7 days)
International Dial-In/UK Local +44 (0)20 3427 0598
UK Toll Free 0800 358 7735
Norway Dial-In +47 2100 0498
USA Toll Free 1866 932 5017
USA Local +1 347 366 9565
Replay Access Number 6041861
Participant information required: Full name & company


Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Washington Post Publisher Will Lewis Steps Down After Layoffs
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



